AMPK Deficiency Induces Corneal Epithelial Barrier Dysfunction by Modulating Energy Homeostasis
Yiran Yang1,2, Ke Yan3, Yunlan Tang1,2
1Henan Provincial People's Hospital, Henan Eye Hospital, Henan Eye Institute, People's Hospital of Zhengzhou University, Henan University People's Hospital, Zhengzhou, Henan, China.
Investigative Ophthalmology & Visual Science
|February 24, 2026
Summary
Adenosine monophosphate-activated protein kinase (AMPK) is crucial for maintaining corneal epithelial barrier function and energy metabolism. Its deficiency impairs barrier integrity and increases inflammation, highlighting AMPK as a therapeutic target for ocular surface diseases.
Area of Science:
- Ophthalmology
- Cell Biology
- Metabolism
Background:
- Corneal epithelial barrier integrity is vital for ocular surface health.
- Energy metabolism plays a significant role in maintaining cellular functions.
- Adenosine monophosphate-activated protein kinase (AMPK) is a key regulator of cellular energy homeostasis.
Purpose of the Study:
- To investigate the role of AMPK in regulating corneal epithelial barrier function.
- To examine the impact of AMPK on corneal epithelial energy metabolism.
- To elucidate the therapeutic potential of targeting AMPK for ocular surface diseases.
Main Methods:
- Generated corneal epithelial specific AMPK knockout mice and utilized human corneal epithelial cells (HCECs) with AMPK knockdown.
- Assessed epithelial barrier function by analyzing tight junction and adherens junction proteins.
- Evaluated energy metabolism through oxygen consumption, mitochondrial dynamics, glucose uptake, and glycolysis assays.
Main Results:
- AMPK deficiency in corneal epithelium led to impaired barrier function, characterized by increased staining and disrupted junctional proteins.
- Knockout mice and HCECs showed compromised oxidative phosphorylation, mitochondrial biogenesis, glucose uptake, and glycolysis.
- Absence of AMPK resulted in elevated inflammation in the corneal epithelium.
Conclusions:
- Disruption of energy metabolism is a key factor in corneal barrier dysfunction.
- AMPK plays a critical role in maintaining corneal epithelial energy metabolism and barrier integrity.
- Targeting AMPK presents a potential therapeutic strategy for ocular surface diseases involving compromised barrier function.
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
8.7K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.7K
PI3K/mTOR/AKT Signaling Pathway
5.8K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.8K


